The efficient execution of apoptotic cell death with the clearance of apoptotic debris by phagocytes is a key regulatory mechanism ensuring tissue homeostasis. Failure in this execution program contributes to the pathogenesis of many human diseases. In this review, we describe the current knowledge regarding the interaction of apoptotic cells with their professional 'captors', the macrophages, with special emphasis on the immunological outcome. Removal of apoptotic cells must be considered as a process that actively delivers signals to polarize macrophages, which are fundamental for the resolution of inflammation. However, the sculpting of macrophage responses by apoptotic cells can be misused under certain inflammatory disease conditions, including tumor development.
Introduction: apoptosis
Tissue homeostasis in metazoans is ensured by two principal control mechanisms. Besides the supply of 'new' cells through activation of the cell cycle of progenitor cells, followed by differentiation into specialists, death of redundant or damaged cells occurs. A spectrum of distinct modes of physiological cell death with varying morphological characteristics was defined in recent years. This includes typical cell death styles, such as apoptosis, autophagy, cornification, and necrosis. Atypical modes of cell death comprise among others mitotic catastrophe, pyroptosis, and entosis (reviewed in Kroemer et al., 2009) . However, apoptosis is considered the predominant way cells die in multicellular organisms, including humans.
Apoptosis is characterized by nuclear condensation and fragmentation, cell shrinkage, and controlled cell disintegration through the formation of membrane vesicles, known as 'apoptotic bodies', whose membrane integrity is maintained (Kerr et al., 1972; Wyllie et al., 1980) . Programmed cell death is energy-dependent and tightly regulated during its initiation, execution, and termination. The whole process is immunologically 'silent' by providing signals for rapid clearance of apoptotic debris by professional phagocytes in vivo (Savill et al., 1989; Savill and Fadok, 2000) . In contrast, necrosis is induced by external insults, such as heat, irradiation, mechanical stress, or toxins, as well as intracellular redox stress, which provoke uncontrolled cell swelling and membrane rupture. Consequently, cytosolic, organelle, and nuclear components are spilled into the surrounding tissue (Savill and Fadok, 2000) . Membrane disintegration is also observed when phagocytosis of apoptotic material is defective, a process termed 'secondary necrosis'. It occurs in vivo when the number of apoptotic cells (ACs) significantly outstrips the phagocytic capacity . Failures to remove apoptotic debris has serious consequences in terms of inflammation and autoimmunity as discussed below (Henson et al., 2001; Savill et al., 2002; Albert, 2004) .
Phagocytosis of apoptotic cells
Clearance of ACs is the final step in the apoptotic program, again being neatly regulated. It can be subdivided into three steps: (1) attraction of phagocytes to the site of tissue damage, (2) specific recognition of ACs by the phagocyte, (3) engulfment of ACs or their fragments. These steps will be explained briefly in the following sections.
Phagocyte attraction
ACs must be removed in order to avoid secondary necrosis. Obviously, a problem arises, as professional phagocytes, such as macrophages, may not be in close proximity to the dying cells. Therefore, it is rational to assume that ACs provide molecular signals to direct the phagocyte towards its 'meal'. Indeed, to date a variety of chemoattractants secreted by ACs were described.
Aminoacyl-tRNA synthetase, an enzyme critical for decoding genetic information in translation, is processed into two fragments during apoptosis. One of them, the endothelial monocyte-activating polypeptide II (EMAP II), was identified as a ligand for the interleukin 8 (IL-8) receptor upon release from cells (Wakasugi and Schimmel, 1999) . IL-8 is an important mediator of leukocyte infiltration into inflamed tissues, with EMAP II mimicking its action. Alternatively, apoptotic fibroblasts secrete increasing amounts of thrombospondin 1 as a recruitment signal for macrophages, which further served as a signal for AC recognition, when being present as a heterodimer with CD36 on the fibroblast surface (Moodley et al., 2003) .
A direct link between the apoptotic machinery and the release of a chemotactic lipid was provided by reports indicating activation of a cytosolic calcium-independent phospholipase A 2 (iPLA 2 ). During apoptosis, caspase-3 cleaves and activates iPLA 2 , which then liberates arachidonic acid and lysophosphatidylcholine (LPC) by hydrolysis of the membrane phospholipid phosphatidylcholine. Both components are released from ACs (Atsumi et al., 2000; Lauber et al., 2003) , but only LPC induces macrophage migration in vitro and in vivo, presumably through coupling to the G protein coupled receptor G2A (Peter et al., 2008) . Thus, LPC exerts some anti-inflammatory properties by ensuring efficient AC clearance through phagocyte attraction (Mueller et al., 2007) . However, its direct impact on macrophages is usually considered as proinflammatory and linked to inflammatory conditions, such as atherosclerosis (Kougias et al., 2006) . Recently, another lipid mediator, sphingosine-1-phosphate (S1P), which is released by ACs (Weigert et al., 2006) , was shown to mediate monocyte/macrophage migration in vitro (Gude et al., 2008) . Intriguingly, S1P exerts potent anti-inflammatory activities on macrophages, as will be discussed later.
Besides providing attraction signals for mononuclear cells, ACs further contribute to the resolution of inflammation by secreting lactoferrin, which potently inhibits granulocyte migration in vitro and in vivo (Bournazou et al., 2008) . Apparently, resolution of inflammation is intrinsically anchored to the apoptotic process, which secures in an elegant way the clearance of ACs by mononuclear phagocytes, and at the same time prevents the attraction of additional inflammatory cells.
Specific recognition
Phagocytes need to discriminate between pathogens, necrotic cells, or ACs in order to put forth a proper immunological response. Therefore, a pattern recognition process operates. An effective way to distinguish necrotic or viable cells from apoptotic ones is sensing molecular changes at their plasma membrane. These ACassociated molecular patterns are also known as 'eat me' flags. They are recognized by phagocyte receptors, often coupled to bridging molecules, which serve to strengthen their recognition (Stuart and Ezekowitz, 2005) .
A hallmark of apoptosis-associated membrane alterations is externalization of phosphatidylserine (PS) (Martin et al., 1995; Verhoven et al., 1995) . In viable cells, PS is mostly restricted to the inner leaflet of the plasma membrane, although exceptions are described (Stowell et al., 2008) . Phospholipid asymmetry is secured by aminophospholipid translocase, which 'flips' PS back to the inner side of the membrane, once it appears at the outer leaflet. During apoptosis, this translocase activity is disrupted, which prevents retraction of PS from the outer cell surface (Bratton et al., 1997) . Additionally, PS exposure is enhanced by caspase-3-dependent activation of phospholipid scramblase, an enzyme that promotes an energy-independent, bidirectional scrambling of all classes of phospholipids across the membrane (Frasch et al., 2000) . More recent studies indicate PS oxidation through oxidized cytochrome c prior to its externalization as a prerequisite for phagocyte recognition (Kagan et al., 2003) . Although molecular details of PS exposure during apoptosis are still under debate, it may not be limited to ACs. Necrotic cell death, induced by death ligands, is also characterized by PS externalization in some cells (Brouckaert et al., 2004 ). These necrotic cells are then engulfed by macrophages, and, similar to ACs, do not induce inflammation. Generally, PS might be considered as a marker of diverse types of physiological cell death, associated with anti-inflammatory signaling.
Phagocytic receptors often interact with PS on ACs via specific bridging molecules that either may be ubiquitously expressed or secreted from ACs. The plasma factor b 2 -glycoprotein I binds to its specific receptor upon ligating PS (Cocca et al., 2001) . Mer kinase receptor recognition of PS is mediated via ambilateral Gas6 binding, while the milk-fat globule epidermal growth factor 8 (MGF-E8) connects PS with the vitronectin receptor (VnR) (Wu et al., 2006) . A receptor specific for PS without bridging molecules being involved was the focus of much attention . Although highly debated, recent work suggests that this putative PS receptor is dispensable for the interaction of phagocytes with ACs (Mitchell et al., 2006) . However, searching for PS recognition receptors moves on and recently three novel PS receptors on phagocytes, Stabilin-2 , Tim4 (Miyanishi et al., 2007) , and BAI1 , were identified .
Besides the PS receptor(s), numerous other binding sites on macrophages were implicated in AC recognition. Most of these receptors are employed during engulfment of pathogens or recognition of oxidized lipoproteins (oxLDLs). Among them are the scavenger receptors CD36 (Cobbs et al., 1995; Greenberg et al., 2006) , scavenger receptor A (Platt et al., 1996) or oxidized low-density lipoprotein receptor 1 (Boss et al., 1998) . They recognize oxidized phospholipids on ACs, known as oxLDL-like sites. Furthermore, receptors necessary for pathogen recognition, such as integrin receptors, complement receptors or Fc receptors might be involved (Stuart and Ezekowitz, 2005) . Another interesting alteration at the surface of ACs is modification of CD31. Its expression on viable cells serves as a detachment or 'don't eat me' signal via homophilic interaction with macrophage CD31 . Disrupting this repellent interaction marks cells as a suitable target for phagocytosis.
Removal
Teleologically, signaling pathways towards the engulfment of ACs should emerge from interactions of 'eat me' signals with phagocyte receptors. Following this, the cytoskeleton of the phagocyte is rearranged, resulting in a 'zipper-like' ingestion process. Therefore, phagocytic receptors may be mechanistically linked to actin filaments, i.e., the cytoskeleton. Unfortunately, no direct connection was proven so far, but two distinct signaling modules mediating engulfment were identified by genetic studies of phagocytosis deficient Caenorhabditis elegans mutants (Gumienny et al., 2001 ). The proteins forming these complexes have mammalian homologs, whose functional properties in phagocytosis of ACs are now being confirmed (Lauber et al., 2004) .
One complex, consisting of CrkII, ELMO, and DOCK180, is recruited to the plasma membrane in nascent phagosomes, serving as a guanine nucleotide exchange factor for the G-protein Rac1, which then induces cytoskeletal changes (Wu et al., 2006) . The Crk-ELMO-DOCK180 complex is activated downstream of VnR (Akakura et al., 2004) or Mer (Wu et al., 2006) and thus links PS recognition on ACs to phagocytosis. Rac1 activation can also be achieved via GULP, which transmits signals downstream of the interaction between ABC1 on ACs and CD91 on the phagocyte membrane (Lauber et al., 2004) . However, mechanistic studies are obscure.
Distinct macrophage phenotypes
Since Mackaness and colleagues first described classically activated macrophages as major immune effector cells (Mackaness, 1964) , considerable knowledge has been gained concerning distinct macrophage populations, with diverse functional roles. The remarkable plasticity of macrophage responses was classified towards two extremes: M1 and M2 macrophages. The term classical activated macrophage (or M1) defines a phenotype produced in response to infection or injury. It is characterized by a high bactericidal competence, i.e., the production of reactive oxygen species (ROS), nitrogen species, as well as proinflammatory cytokines, such as tumor necrosis factor a (TNF-a), IL-1b, IL-6, and IL-12 (O'Shea and Murray, 2008) . M2 macrophages alone comprise a broad spectrum of phenotypes with different biochemistry and function. To appreciate the functional repertoire of macrophages, taking into consideration the reports on intermediate or hybrid activation states, Mosser and Edwards avoided the term M2 macrophages and used the operative useful discrimination between regulatory and wound-healing macrophages, considering their implication in immune regulation and wound healing (Mosser and Edwards, 2008) .
Originally, IL-4 and IL-13 were described as alternative macrophage activators, because they attenuate the production of proinflammatory mediators, i.e., proinflammatory cytokines, nitric oxide (NO), or ROS. At the same time, alternative macrophage activation enhances the expression of IL-10, arginase 1/2, or the mannose receptor. These macrophages were more recently classified as M2a, or wound-healing macrophages (Mantovani et al., 2004b) . The latter nomenclature refers to the secretion of extracellular matrix components, thus fostering woundhealing (Mosser and Edwards, 2008) .
Regulatory or M2c macrophages are generated by environmental stimuli, such as IL-10, glucocorticoids, prostaglandins, and also ACs. Compared to wound-healing macrophages, they do not produce extracellular matrix, but rather secrete high levels of IL-10 and transforming growth factor b (TGF-b), thus showing a pronounced immune regulatory function. M2b macrophages also exert immunoregulatory functions and are induced by combined exposure to immune complexes and TLR or IL-1 receptor ligands. Similar to M2a and M2c, they show increased IL-10 but reduced IL-12 levels but still produce proinflammatory cytokines, such as TNF-a, IL-6, and IL-1. Because they provoke strong Th2 responses they were originally named type II macrophages (Mantovani et al., 2004b; Mosser and Edwards, 2008) . Even though these classifications tend to specifically describe macrophage subtypes, they still display only extremes of a continuum, especially considering that hybrid-type cells exist (extensively reviewed in Mantovani et al., 2004b; Mosser and Edwards, 2008) .
Multiple interactions between macrophages and apoptotic cells Attenuation of proinflammatory responses
In the late 1990s, Voll and co-workers observed that lipopolysaccharide (LPS)-induced TNF-a and IL-1b expression in monocytes was reduced after co-culture with apoptotic lymphocytes, whereas IL-10 was upregulated (Voll et al., 1997) . In the meantime these early studies were supported by many others, corroborating the ability of ACs to repress macrophage inflammatory responses (Figure 1) .
ACs provide signals to directly influence the phenotype of their 'captors', thereby dampening inflammation. Obviously, suppression of inflammation is an intrinsic feature of AC death, even though phagocytosis per se is not required. Studies in CD14 deficient mice showed impaired phagocytosis of ACs but elevated TGF-b and reduced TNF-a secretion (Devitt et al., 2004) . This was supported by Lucas et al., using CD36 and a v b 3 integrin deficient mice. CD36 and a v b 3 integrin were necessary for proper AC clearance, but were not essential for immunosuppression in, e.g., lowering proinflammatory TNF-a production (Lucas et al., 2006) .
Although alternative activation of macrophages by the interaction with ACs is widely accepted, the type of macrophage/AC interaction as well as underlying molecular signaling circuits are ill-defined. Some of the inhibitory effects were attributed to PS, but generalized effects and details are controversial as outlined in the following sections.
Attenuated ROS and NO formation
The bactericidal capacity of macrophages is in part mediated by the production of ROS (Forman and Torres, 2002) and NO. In response to LPS and/or interferon g (IFN-g), macrophages upregulate the inducible NO synthase (iNOS), which catalyzes the oxidation of L-arginine to Lcitrulline and NO (Bogdan, 2001 ). While it is accepted that ACs reduce NO production, several explanations are discussed. Reduced NO formation can result from increased arginase expression. Two isoforms, arginase 1 and 2, metabolize L-arginine to urea and ornithine, thus competing with iNOS for the same substrate (Morris, 2004) . It is proposed that ACs upregulate arginase 1, at the same time downregulating iNOS in a TGF-b-and PS-dependent manner (Freire-de-Lima et al., 2006). ACs provide signals (blue) that shift macrophages towards a 'regulatory' phenotype, which is characterized by inhibition of proinflammatory mediators (red) as well as induction of anti-inflammatory mediators (black). ™ stimulation; ® inhibition; for detailed information see text. ACs, apoptotic cells; Arg1,2, arginase 1 or 2; COX-2, cyclooxygenase-2; EIF4E, eukaryotic initiation factor 4E; HO-1, heme oxygenase-1; IDO, indoleamine-2,3-dioxygenase; LPC, lysophosphatidylcholine; NCoR, nuclear receptor co-repressor; PAF, platelet-activating factor; PPARg, peroxisome proliferator activated receptor g; PS, phosphatidylserine; ROS, reactive oxygen species; S1P, sphingosine-1-phosphate; VnR, vitronectin receptor; MFG-E8, milk-fat globule epidermal growth factor 8.
Others reported upregulation of arginase 2 by AC. Arginase 2 expression occurred in response to soluble factors secreted by AC, was cell-cell-contact and TGFb-independent and left iNOS expression unaltered . Although reduced NO formation was linked to the TGF-b/arginase 1 axis (Boutard et al., 1995) , it was questioned whether TGF-b alone induces arginase 1 expression in RAW264.7 macrophage (Barksdale et al., 2004) . In addition, expression of arginase 1 occurred late as compared to NO inhibition, which argues for additional inhibitory mechanisms. It is likely that the rapid induction of arginase 2 observed with ACs contributes to reduce NO formation in alternatively activated macrophages with secondary and late inhibition being, at least in part, TGF-b-mediated.
Another feature of macrophage cytotoxicity is the production of ROS. The oxidative burst is initiated by PKCadependent phosphorylation of p47 phox , activation of Rac1/2 and assembly of the NADPH oxidase complex (Larsen et al., 2000; Lambeth, 2004) . ROS formation in macrophages was inhibited by apoptotic Jurkat cells as well as PS-enriched viable Jurkat cells, whereas oxidized PS was even more effective (Serinkan et al., 2005) . Transwell-experiments pointed to the requirement for cellcell-contacts and possibly a PS-dependent pathway. Mechanistically, Johann et al. (2006) suggested the peroxisome proliferator activated receptor g (PPARg), activated by ACs by a thus far unknown mechanism, to account for ROS inhibition. PPARg is known for its antiinflammatory properties (Ricote and Glass, 2007) and activation of PPARg with synthetic agonists induced a direct protein interaction with PKCa, thereby interfering with translocation of the kinase from the cytosol to the membrane, which is a prerequisite for the oxidative burst . NADPH oxidase complex assembly is initiated by PKCa-dependent p47 phox phosphorylation, which is attenuated by ACs. Although activation of Rac1 by ACs was also described, this seems insufficient to overcome reduced PKCa activation and concomitant ROS production.
Modulation of cytokine expression
Besides repressing ROS and NO formation, ACs strongly suppress proinflammatory cytokine expression of, e.g., IL-1b, TNF-a, IL-6, and IL-12, subsequent to LPS stimulation. Different explanations are plausible and reduction was bound to autocrine signaling of TGF-b, platelet-activating factor (PAF) and prostaglandin E 2 (PGE 2 ), all of which are released from macrophages in response to ACs in a PS-dependent manner. The reduction in IL-1b, IL-8, and TNF-a, observed with incubation periods of more than 18 h, was abolished by a neutralizing TGF-bantibody, blocking cyclooxygenase (COX) with indomethacin or a PAF receptor antagonist (Fadok et al., 1998) .
A prominent cytokine being upregulated in macrophages in response to ACs is TGF-b. Supportive argumentation for a PS-dependence came from experiments with human monomyelocyte cells, which do not expose PS at their surface during UV-induced apoptosis. These cells failed to promote TGF-b1 secretion, while TGF-b release was observed with PS-exposing apoptotic Jurkat cells (Huynh et al., 2002) . Moreover, masking PS on irradiated tumor cells by annexin V averted TGF-b production in macrophages (Bondanza et al., 2004) . A recently reported PS receptor, Stabilin-2, mediated AC engulfment and anti-Stabilin-2 antibodies induced TGF-b, supporting the indirect notion that PS receptor activation mediates TGF-b release . Despite that the receptor remains uncertain, enhanced TGF-b secretion in response to ACs is facilitated by transcriptional and translational regulation. TGF-b mRNA transcription was sensitive to p38 MAPK, Erk, and Jnk inhibition, while translation demands Rho kinase, followed by phosphorylation of PI3K/Akt and mTOR, and subsequent activation of eukaryotic initiation factor 4E (Xiao et al., 2008) .
Inhibition of NF-kB
Even though TGF-b is a known anti-inflammatory mediator (Letterio and Roberts, 1998) , reduced cytokine expression is primarily associated with inhibition of NFkB, a major transcriptional regulator of cytokine expression (Bonizzi and Karin, 2004) . Identifying Mer tyrosine kinase receptor as a potential candidate to block NF-kB, strengthened a role for PS in this process. Overexpression of a Mer kinase-dead mutant relieved NF-kB inhibition (Tibrewal et al., 2008) . In dendritic cells, the Mer kinase receptor was associated with NF-kB inhibition in response to ACs as demonstrated by using Mer receptor knockdown cells and blocking antibodies (Sen et al., 2006) . Future studies need to provide mechanistic details, especially as a direct role for inhibition of proinflammatory cytokine formation via this receptor is still missing.
Despite a potential role of the Mer kinase or TGF-b in downregulating proinflammatory mediators, the macrophage shift towards an anti-inflammatory phenotype also occurred independently of PS and TGF-b, especially at earlier times, i.e., below 18 h. Cvetanovic and Ucker (2004) provided evidence that NF-kB, although being inactive, binds to the DNA, implying that co-activators/ co-repressors are involved. Recently, it was verified that NF-kB inhibition results from the interplay with PPARg and the nuclear receptor co-repressor (NCoR). NCoR is a co-repressor bound to NF-kB sites under basal conditions. In response to LPS, NCoR is degraded, co-activators bind and initiate transcription (Pascual et al., 2005) . Co-activator/co-repressor exchange is a common phenomenon switching from gene repression to gene activation and vice versa (Gao et al., 2005) . The process is regulated by co-repressor removal, its ubiquitination/ 19S proteasomal degradation, followed by subsequent co-activator recruitment. ACs induce PPARg-sumoylation, which is targeted to NCoR and prohibits its clearance from kB sites within proinflammatory promoters (Jennewein et al., 2008) . Taking into consideration that PPARg also inhibits NF-kB transactivation classifies PPARg as an eminent factor in shaping regulatory macrophage phenotypes, although at present the receptors initiating PPARg sumoylation remain unclear. For tumorassociated macrophages (TAMs), it has been proposed that p50 homodimer formation accounts for NF-kB inhibition (Saccani et al., 2006) . Although not formally shown for macrophages polarized by ACs, it opens the possibility that, depending on the activation signal, distinct but qualitatively equivalent mechanisms interfere with the canonical NF-kB pathway.
S1P and IL-10 in regulatory macrophage polarization
Besides recognition-dependent signals, soluble factors released from ACs were shown to polarize macrophages. Examples comprise IL-10 (Gao et al., 1998) , TGF-b (Chen et al., 2001) , and more recently the lipid mediator S1P (Weigert et al., 2006) .
During a co-culture of tumor cells with primary macrophages, apoptosis in tumor cells occurred and in turn macrophages were alternatively activated. Interrupting apoptosis by overexpressing Bcl-2 in tumor cells or using apoptosis resistant tumor cell lines failed to induce the accompanying anti-inflammatory macrophage phenotype shift. Interestingly, conditioned medium from ACs also polarized macrophages, which argues for a soluble factor transmitting information to macrophages. S1P, described for its anti-inflammatory (Idzko et al., 2002; Xin et al., 2004) and anti-apoptotic effects (Gomez-Munoz et al., 2003) , emerged as a potential candidate. Indeed, S1P is released from ACs, protected macrophages against apoptosis, reduced TNF-a and IL-12p70 secretion, but enhanced the expression of IL-10 and IL-8 .
Expression of macrophage IL-10 in response to ACs was first observed in the seminal paper by Voll et al. (1997) . IL-10 emerged as a key regulator suppressing Th1 responses and IL-10-deficient mice develop chronic intestinal inflammation, as they apparently cannot restrict inflammation (Kuhn et al., 1993) . Especially in macrophages, which express high levels of IL-10R, the immunosuppressive role of IL-10 was intensively characterized. IL-10 activates STAT3 homodimer formation and DNA binding, with the consequence of suppressing proinflammatory mediator transcription (O'Shea and Murray, 2008) . Regarding the question how IL-10 is induced by ACs, it is tempting to attribute this to COX-2 expression (Strassmann et al., 1994) . COX-2 is rate limiting in converting arachidonate to PGE 2 , with the further conversion of PGE 2 towards anti-inflammatory mediators, such as the PPARg agonist 15d-PGJ 2 or resolvins (Serhan and Savill, 2005) . COX-2 expression in macrophages by ACs is either facilitated via VnR (Freire-deLima et al., 2000) , which requires cell-cell-contact between AC and macrophages, or by AC-derived S1P and HuR-mediated COX-2 RNA stabilization (Johann et al., 2008) . Strikingly, efferocytosis-dependent PGE 2 production was shown to markedly impair pathogen clearance by lung alveolar macrophages in vivo, consistent with elevated levels of IL-10 ( Medeiros et al., 2009 ). This was dependent on E prostanoid receptor 2-induced cyclic AMP generation. cAMP signaling is considered a hallmark of regulatory macrophages in the resolution phase of inflammation, generally accompanied by COX-2 expression and secretion of high levels of IL-10 (Bystrom et al., 2008) .
A knockdown of sphingosine kinase 2 in tumor cells reduced S1P levels in the supernatant of ACs, at the same time interrupting to a great extent the immunosuppressive properties of AC supernatants. S1P not only induced COX-2, but also upregulated heme oxygenase-1 (HO-1) in a biphasic manner. Early expression of HO-1 after 6 h was transmitted by activating the S1P receptor 1, whereas a second wave of expression was attributed to autocrine signaling of vascular endothelial growth factor A (Weis et al., 2009) . HO-1 catalyzes the rate limiting step in the degradation of heme to biliverdin, ferrous iron, and carbon monoxide and is known for its anti-apoptotic and anti-inflammatory properties (Otterbein et al., 2000; Deshane et al., 2005; Kim et al., 2006) . HO-1 was causatively involved in upregulation of Bcl-2 and Bcl-X L , explaining the mechanism behind S1P-mediated protection from apoptosis (Weis et al., 2009 ).
Impact of AC recognition on adaptive immunity
HO-1 induction by ACs also accounts for expression of the adenosine receptor A 2A (Weis et al., 2009) , which is known to convey immunosuppression and blocks IL-12 formation (Hasko et al., 2007) . IL-12 is necessary to activate Th1 inflammatory responses, provoking maturation of naive CD4 q T cells to Th1 effector cells and causing IFN-g secretion by CD8
q T cells as well as natural killer cells. Thus, reducing the production of IL-12 per se elicits immune suppression. Furthermore, interaction with ACs downregulated the major histocompatibility complex II (MHC II) in macrophages, which is necessary to facilitate antigen presentation to T cells. There is experimental evidence suggesting that MHC II reduction as well as reduced IL-12 secretion is IL-10-dependent (Sica et al., 2000) . A reduction in MHC II suppresses T cell activation, which may account for a lower IFN-g, but higher IL-4 expression. Along this argumentation, the overall ability of AC-polarized macrophages to shift T cell cytokine secretion towards a Th2-like phenotype was largely prevented by neutralizing IL-10 ( Girkontaite et al., 2007) . Recent data also revealed an increased expression of indoleamine-2,3-dioxygenase (IDO) in AC-polarized macrophages (Weis et al., 2009) . IDO metabolizes tryptophan and was implicated in blocking T cell proliferation (Munn et al., 1999) . It is proposed that either low tryptophan concentrations, being an essential amino acid for T cells, or tryptophan metabolites, such as 3-OH-kynurenine and 3-OH-anthranilic acid, inhibit proliferation and induce apoptosis (Terness et al., 2006) .
Besides suppressing Th1 effects, ACs also induce tolerance by generating so-called 'helpless' CD8 q T cells.
Griffith et al. observed that ACs fostered the development of CD8
q suppressive T cells without activating CD4
q T helper cells. CD8 q T cells without 'help' were shown to secrete TRAIL and undergo activation-induced cell death (Griffith et al., 2007) . Thus, evidence is emerging that AC-activated macrophages are deficient in Th1 cell activation via distinct mechanisms. However, a more detailed understanding of the relative impact of these processes and consequences on cytotoxic T cell priming is lacking. In summary, recent research indicated that the interaction of ACs with professional phagocytes suppresses antigen-dependent activation of adaptive immune responses. Phagocytosis of ACs might be a mechanism to secure self-tolerance by removing potential antigens and by reducing their presentation/recognition. Failures in this program will lead to autoimmunity, as discussed in more detail below.
Interactions between apoptotic cells and macrophages in disease
The interaction of ACs with macrophages has a high potential in shaping and coordinating immune responses. M1 activation triggering macrophage cytotoxicity against tumor or glomerular cells can be suppressed by the uptake of apoptotic debris (Duffield et al., 2001) . To generalize, an efficient interaction of ACs with phagocytes appears as a prerequisite for the resolution of inflammation (Serhan and Savill, 2005) . In this scenario, inflammatory granulocytes as well as T cells are eliminated by apoptosis and subsequently engulfed by phagocytes, which themselves disappear from the inflamed tissue through lymph drainage. As predicted for the physiological role of apoptosis, the process initiated by dying cells and culminating in a phenotype switch of macrophages maintains tissue homeostasis, by reducing tissue mononuclear and lymphoid cell numbers to a physiological level and function. In this autoregulatory system the end, i.e., apoptosis, programs the beginning, i.e., the restoration of a physiological environment. Any interference in the fragile balance of inflammation initiation vs. its resolution may have severe implications for the development of pathologies, such as atherosclerosis, fibrosis, or auto-immunity (Opferman and Korsmeyer, 2003; Vandivier et al., 2006; Liang et al., 2007) .
Autoimmunity
One of the most prominent examples linking apoptosis to pathology is the maintenance of self-tolerance, with defects leading to autoimmunity. Autoimmune diseases may arise from defective elimination of autoimmune T or B cells. Recognition of pathogens by the immune system induces rapid amplification of lymphocyte populations, and once the pathogen is destroyed tissue homeostasis must be restored. In addition, impaired clearance of ACs will enhance immune responses directed towards the body's own tissues, as AC can be considered as a source for intracellular antigens, thus fostering autoantibody production (Michlewska et al., 2007) . Supportive evidence for this concept emerged from observations linking defects in ACs clearance to autoimmune diseases, such as systemic lupus erythematosus (SLE). Furthermore, macrophages from diabetes-prone NOD mice phagocytose ACs less efficient compared to diabetesresistant strains (O'Brien et al., 2002) .
Defects in the complement pathway in mice and humans provokes accumulation of ACs and the development of SLE (Erwig and Henson, 2007) . Likewise, mice deficient in Mer (Scott et al., 2001) or MGF-E8 (Hanayama et al., 2006) show persistence of ACs and autoantibodies against nuclear antigens. Nevertheless, studies in mice deficient in CD14 (Devitt et al., 2004) , efferocytosisassociated integrins, and CD36 (Ravichandran and Lorenz, 2007) revealed that accumulation of ACs per se do not necessarily initiate autoimmunity. These controversial observations predict that a variety of phagocytic receptors regulate efficient uptake of ACs and that probably not all of them trigger anti-inflammatory signals upon ligand binding. There is an obvious discrepancy between the phenotype of MGF-E8 vs. b 3 -integrin knockout mice, although both molecules should sense PS on the surface of ACs. A general pattern emerges, indicating that disruption of PS recognition might be involved in clearance defective-associated autoantibody production, thus underscoring the anti-inflammatory potential of PS. In support of this argumentation, blocking PS-dependent recognition of irradiated lymphoma cells by annexin coating prior to their injection in tumor-bearing mice increased their potential to trigger a tumor-specific immune response (Bondanza et al., 2004) .
Unchecked inflammation
Deregulated AC clearance might trigger chronic inflammation due to enhanced secondary necrosis. This was demonstrated by an adoptive transfer of Mer knockout versus wildtype macrophages in irradiated atherosclerosis-susceptible low-density lipoprotein receptor-deficient mice. The Mer deficiency resulted in accumulation of ACs, associated with a proinflammatory milieu and enhanced atherosclerotic lesion development (Ait-Oufella et al., 2008) . Downregulating phagocytosis of ACs might foster the interaction of ACs with non-professional phagocytes (Michlewska et al., 2009) . As demonstrated for microvascular endothelial, the uptake of ACs under these conditions perpetuates rather than attenuates inflammation (Kirsch et al., 2007) .
Conceptually, the continuing presence of ACs can affect the microenvironment to reach a chronic antiinflammatory stage. Fibrosis is considered to be Th2-dependent and is, among multiple variables, associated with the presence of alternatively activated immune cells, specifically wound-healing macrophages (Meneghin and Hogaboam, 2007) . Fibrotic diseases of the lung, such as cystic fibrosis, chronic obstructive pulmonary disease, or idiopathic pulmonary fibrosis, reveals accumulation of ACs . Although a mechanistic link between the persisting ACs and macrophage polarization under these conditions is not firmly established, it is tempting to speculate that the continued presence of ACs skews macrophage to a dominant M2 phenotype, thus enhancing the production of profibrotic mediators. Critical signaling components in fibrosis are TGF-b, Th2 cytokines, such as IL-4/IL-13, and chemokines (Wynn, 2008) . They modulate immune cell activation, but also have direct implications in recruitment, differentiation, and survival of the critical profibrotic cell type, the myofibroblast (Wynn, 2007) . Profibrotic mediators are produced by distinct macrophage subsets, with TGF-b being the most prominent in response to ACs (Gordon, 2003) . Upon the contact of ACs with HC-11 epithelial cells, co-culture supernatants mimicked TGF-b-induced fibrotic matrix-depositing fibroblast responses, characterized by TIMP-1 or collagen-I expression (Golpon et al., 2004) . The uninterrupted co-existence of ACs with professional and non-professional phagocytes, due to clearance defects, might sustain TGF-b. In addition, uncleared ACs themselves are a potential source for immunomodulatory mediators, such as TGF-b (Chen et al., 2001) , IL-4 (Hodge et al., 2002) , and S1P (Weigert et al., 2006) . In the context of fibrosis, S1P was recently demonstrated to induce fibroblast/myofibroblast transformation and to promote matrix deposition (Keller et al., 2007; Swaney et al., 2008) . One can conclude that ACs have the capacity either directly or indirectly (via macrophage polarization) to fuel progression towards organ fibrosis. A transition of ACs to secondary necrotic cells releases efferocytosis inhibitors, such as high mobility group box (HMGB)1 (Liu et al., 2008) , which may trigger inflammation in naive recruited immune cells, thus establishing a type of feed-forward mechanism towards fibrosis (Figure 2) .
The proposed mechanisms outlined for fibrosis are an established paradigm for the development of solid tumors, which are often assigned as 'wounds that do not heal' (Schafer and Werner, 2008) . A growing tumor needs to suppress an anti-tumor immune response , and not surprisingly accumulation of alternatively activated immune cells, such as TAMs (Mantovani et al., 2004a) , is a prominent feature of most human neoplasms (Bingle et al., 2002) . Developing tumors also undergo clonal selection due to genetic instability, or nutrient deprivation, with accompanying high rates of dying cells. Intriguingly, a mechanistic connection Figure 2 Cell death in fibrotic disorders. Inflammatory macrophages (M1) produce cytotoxic mediators at sites of tissue injury. As a consequence, resident tissue cells (RTCs) undergo apoptosis. These apoptotic cells (ACs) secrete chemoattractants to amplify immune cell infiltration into the injured tissue, and to polarize macrophages to an anti-inflammatory phenotype (M2). If the clearance of ACs fails, e.g., due to TNF-a secretion by inflammatory cells or excessive apoptosis, ACs progress towards secondary necrosis or deliver continuous anti-inflammatory and profibrotic signals. Necrotic cells (NCs) foster inflammation and inhibit efferocytosis due to HMGB1 secretion. Finally, AC-or M2-dependent myofibroblast (MF) generation enhances ECM deposition and fibrotic diseases. Red arrows indicate mechanisms provoking defective ACs clearance. NO, nitric oxide; O 2 -, superoxide; EMAPII, endothelial monocyte-activating polypeptide II; LPC, lysophosphatidylcholine; S1P, sphingosine-1-phosphate; HMGB, high mobility group box; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor; ECM, extracellular matrix.
between these cellular patterns is striking. Macrophages that were exposed to apoptotic tumor cells were incapable of killing viable tumor cells (Reiter et al., 1999 ) and apoptotic tumor cell-derived S1P promoted alternative macrophage activation in a direct co-culture system . Interestingly, interfering with S1P signaling, by using a monoclonal antibody directed against this lipid, hindered tumor xenograft angiogenesis and survival in several tumor cell lines (Visentin et al., 2006) , corroborating the contribution of S1P in tumor progression.
A detailed mechanistic understanding how ACs influence immunity will be worthwhile, as it might open new avenues for the development of novel therapeutic approaches targeting these signaling pathways. These include stimuli to foster the uptake of ACs as described for lovastatin (Morimoto et al., 2006) , as well as antagonists of the AC/phagocyte interaction. Intriguingly, a careful evaluation of the mode of tumor cell death induced by chemotherapeutic agents, which should trigger necrosis rather than apoptosis to cross-activate the immune system, is a promising method combining chemo-and immunotherapy (Apetoh et al., 2007; Zitvogel et al., 2008) .
